Literature DB >> 4347084

Antineoplastic and immunosuppressive drugs. II. Therapeutic uses.

M D Cridland.   

Abstract

Mesh:

Substances:

Year:  1972        PMID: 4347084     DOI: 10.2165/00003495-197203050-00003

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  83 in total

1.  TREATMENT OF ACTIVE CHRONIC HEPATITIS AND LUPOID HEPATITIS WITH 6-MERCAPTOPURINE AND AZOTHIOPRINE.

Authors:  I R MACKAY; S WEIDEN; B UNGAR
Journal:  Lancet       Date:  1964-04-25       Impact factor: 79.321

2.  COMBINED VINBLASTINE AND CHLORAMBUCIL THERAPY OF HODGKIN'S DISEASE.

Authors:  M J LACHER; J R DURANT
Journal:  Ann Intern Med       Date:  1965-03       Impact factor: 25.391

3.  Vincristine in the treatment of lymphomas and leukemias.

Authors:  R A BOHANNON; D G MILLER; H D DIAMOND
Journal:  Cancer Res       Date:  1963-05       Impact factor: 12.701

4.  Clinical evaluation of CB 1348 in leukemias and lymphomas.

Authors:  C A DOAN; B K WISEMAN; B A BOURONCLE
Journal:  Ann N Y Acad Sci       Date:  1958-04-24       Impact factor: 5.691

5.  Treatment of the chronic leukaemias.

Authors:  D A GALTON
Journal:  Br Med Bull       Date:  1959-01       Impact factor: 4.291

6.  Thrombocytopenic purpura in patient with autoimmune haemolytic anaemia, successfully treated with mercaptopurine.

Authors:  M H Tattersall
Journal:  Br Med J       Date:  1967-07-08

Review 7.  Experimental studies relating to the production and clinical testing of anti-human lymphocyte serum.

Authors:  W J Martin
Journal:  Med J Aust       Date:  1969-08-30       Impact factor: 7.738

8.  Combination chemotherapy in the treatment of advanced Hodgkin's disease.

Authors:  V T Devita; A A Serpick; P P Carbone
Journal:  Ann Intern Med       Date:  1970-12       Impact factor: 25.391

9.  Approaches to improving the chemotherapy of Hodgkin's disease.

Authors:  E Frei; V T DeVita; J H Moxley; P P Carbone
Journal:  Cancer Res       Date:  1966-06       Impact factor: 12.701

10.  The increasing incidence of central nervous system leukemia in children. (Children's Cancer Study Group A).

Authors:  A E Evans; E S Gilbert; R Zandstra
Journal:  Cancer       Date:  1970-08       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.